OpenLegislation

Regulation 4 Amendment of regulation 2 in relation to England, Scotland and Wales (interpretation)

Original text. Later amendments are not shown.

In regulation 2(1)f1, insert at the appropriate place—

  • ““statistical review” means a review of the statistical sections of the written notice which a manufacturer or their UK responsible person submits to the Secretary of State pursuant to regulation 16(1) or 29(1) in respect of an intended clinical investigation of a relevant device;”.

Annotations

Footnotes

f1

Amended by S.I. 2003/1697, 2007/400, 2008/2936, 2012/1426, 2013/2327, 2019/791, 2021/873, 2021/910 and section 41(4) of the Medicines and Medical Devices Act 2021 (c. 3).